Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

March 28, 2013

NON-MS related — TIRED of UNWANTED Solicitation calls or emails?

  • Misc. Tips - Non MS Related
    /
Visit this link – to learn how YOU MIGHT opt-out: https://www.optoutprescreen.com/faq.htm#1_3 The above information pertains to the USA This information…
Misc. Tips - Non MS Related

March 28, 2013

Now approved—a new pill for relapsing forms of multiple sclerosis (MS)

  • MS Drug Therapies
    /
  • Oral MS Medications
    /
Tecfidera was approved by the FDA for the treatment of people with relapsing forms of MS. Taking Tecfidera What you…
MS Drug Therapies

March 27, 2013

Biogen’s MS ORAL Drug Tecfidera (BG12) Wins FDA Nod

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
  • Oral MS Medications
    /
By John Gever, Senior Editor, MedPage Today Published: March 27, 2013 SILVER SPRING, Md. — Dimethyl fumarate has won FDA approval…
MS Drug Therapies

March 27, 2013

Novartis confirms growing Gilenya® clinical and real-world experience as number of patients treated increases to over 63,000

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
  • Oral MS Medications
    /
Growing global evidence base reinforces consistent and sustained efficacy of first once-daily oral multiple sclerosis treatment Up to seven years of clinical…
MS Drug Therapies

March 27, 2013

Major Advance in Understanding Risky but Effective Multiple Sclerosis Treatment

  • Multiple Sclerosis
    /
  • Stem Cell Related
    /
Mar. 26, 2013 — A new study by multiple sclerosis researchers at three  Canadian centres addresses why bone marrow transplantation (BMT)…
Multiple Sclerosis

March 27, 2013

Biogen Idec (BIIB) PLEGRIDY Met Primary Endpoint in Phase 3 ADVANCE

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
March 20, 2013 Biogen Idec, Inc. (Nasdaq: BIIB) announced the positive, full first-year results from its two-year pivotal Phase 3 ADVANCE…
MS Drug Therapies

March 25, 2013

Decision Looms on New Multiple Sclerosis Drug

  • Oral MS Medications
    /
March 25, 2013 Will good news from Europe echo on this side of the Atlantic within the next few days? Biogen Idec (NASDAQ:BIIB  )…
Oral MS Medications

March 25, 2013

Oral Laquinimod for Multiple Sclerosis Passes Phase 3 Extension

  • MS Drug Therapies
    /
  • Oral MS Medications
    /
March 21, 2013 Teva Pharmaceutical and Active Biotech announced top-line results from an open-label extension of the Phase 3 ALLEGRO study,…
MS Drug Therapies

March 25, 2013

Atrophy of the thalamus is an important predictor of clinically definite MS, study shows

  • MS Research Study and Reports
    /
Multiple Sclerosis research: the thalamus moves into the spotlight This 3D view shows a composite of the thalamus of healthy…
MS Research Study and Reports

March 24, 2013

When Life Gets in the Way – a patient’s story

  • An MS Patients Story
    /
When Life Gets in the Way By Cherie C. Binns RN BS MSCN I have not written much here in…
An MS Patients Story

Categories

Latest Blog Posts